ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Pharmaceuticals

South Korea's Celltrion exports coronavirus tests to US

Diagnostic kits to help fill US testing gap

Celltrion has been developing testing kits and a treatment for the coronavirus. (Photo courtesy of Celltrion)

SEOUL -- South Korea's Celltrion has started selling coronavirus screening kits in the U.S. to help bridge the country's testing gap, the company said Wednesday.

The Incheon-based drugmaker expects both its antigen and antibody testing kits to be approved for sale in the U.S. by mid-August. A U.S. subsidiary will distribute the kits.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more